Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: May 22, 2024
Date Accepted: Jun 20, 2025

The final, peer-reviewed published version of this preprint can be found here:

Evaluating the Effectiveness of Mobile Apps on Medication Adherence for Chronic Conditions: Systematic Review and Meta-Analysis

Lanke V, Trimm K, Habib B, Tamblyn R

Evaluating the Effectiveness of Mobile Apps on Medication Adherence for Chronic Conditions: Systematic Review and Meta-Analysis

J Med Internet Res 2025;27:e60822

DOI: 10.2196/60822

PMID: 40743450

PMCID: 12312993

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Evaluating the effectiveness of mobile applications on medication adherence for chronic conditions: Systematic Review and Meta-analysis

  • Vaidehee Lanke; 
  • Kevin Trimm; 
  • Bettina Habib; 
  • Robyn Tamblyn

ABSTRACT

Background:

Medication adherence is crucial in managing chronic conditions, yet only 50% of chronically ill patients take medications as prescribed, leading to poor health outcomes. Mobile applications include a variety of possible features that have the potential to support and improve medication adherence.

Objective:

The purpose of this systematic review was to evaluate the effectiveness of mobile applications in promoting medication adherence for patients managing chronic conditions.

Methods:

MEDLINE (Ovid), Embase (Ovid) and Cochrane Central Register of Controlled Trials databases were searched for randomized controlled trails (RCTs) evaluating the effectiveness of mobile app interventions in improving medication adherence in patients with chronic conditions. Meta-analyses were performed on medication adherence scores, categorized by adherence measurement scale, and bias assessment was conducted using the Cochrane Risk of Bias tool.

Results:

This review included 14 RCTs published between 2014 to 2022, with sample sizes between 57 to 412 participants and the length of interventions ranging from 30 days to 12 months. A range of patient populations were evaluated in the included studies, including those with Parkinson’s disease, coronary heart disease, psoriasis, and hypertension, with the latter being the most common. All 14 studies reported that app interventions improved medication adherence and 10 RCTs demonstrated statistically significant improvement in medication adherence. Three separate sets of meta-analyses and difference in difference analyses were conducted on studies, categorized by the 3 scales used in individual studies: the 8-item Morisky Medication Adherence Scale, 4-item Morisky Medication Adherence Scale and percentage adherence scale. Each set of analyses demonstrated that app-based interventions improved medication adherence.

Conclusions:

From the studies included in this review, mobile apps, designed for a range of conditions with a range of features, can improve medication adherence and may be a tool to successfully manage chronic conditions. Clinical Trial: PROSPERO International Prospective Register of Systematic Reviews CRD42023488188


 Citation

Please cite as:

Lanke V, Trimm K, Habib B, Tamblyn R

Evaluating the Effectiveness of Mobile Apps on Medication Adherence for Chronic Conditions: Systematic Review and Meta-Analysis

J Med Internet Res 2025;27:e60822

DOI: 10.2196/60822

PMID: 40743450

PMCID: 12312993

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.